This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
ALBANY, N.Y., Feb. 1, 2013 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today said it has completed the previously announced acquisition of certain assets of Microsulis Medical Ltd.
Microsulis developed the Acculis MTA microwave ablation system, which utilizes a single, high-power, high-frequency 2.45 GHz saline-cooled applicator that may provide advantages to clinicians and patients, including faster ablation of soft tissue.
"We are excited to welcome the Microsulis team to AngioDynamics," said Joseph M. DeVivo, President and CEO of AngioDynamics. "With the addition of microwave, we have a complete offering of thermal and non-thermal technologies, further building on our status as a market-leader in the $250 million global tissue ablation market."
AngioDynamics Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. AngioDynamics' diverse product lines include market-leading ablation systems, fluid management systems, vascular access products, angiographic products and accessories, angioplasty products, drainage products, thrombolytic products and venous products. More information is available at
AngioDynamics, the AngioDynamics logo and Acculis are trademarks and/or registered trademarks of AngioDynamics Inc., an affiliate or a subsidiary.
CONTACT: Company Contact:
Mark Frost, CFO
(800) 772-6446 x1981
Investor Relations Contacts:
EVC Group, Inc.
Greg Gin/Robert Jones
(646) 445-4801; (646) 201-5447
EVC Group, Inc.